Skip to main content
. 2021 Jul 9;16:4739–4753. doi: 10.2147/IJN.S313140

Table 2.

Comparison Between FT-DBA with FDA Approved Commercial Antibody Immunoassay

Commercial Immunoassay (Elecsys SARS-CoV-2 Assay)
Positive Negative Total Sensitivity, (95% CI) Specificity, (95% CI)
FT-DBA Positive 15 0 15 100%(78.3%, 100%) 100%(83.2%, 100%)
Negative 0 20 20
Total 15 20 35

Note: Test agreement was evaluated by Kappa statistics.